DUBLIN–(BUSINESS WIRE)–February 18, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP)
Read moreHome ยป
Novo Nordisk Files for US FDA Approval of Oral Semaglutide for Blood Sugar Control and Cardiovascular Risk Reduction in Adults with Type 2 Diabetes
PLAINSBORO, N.J., March 20, 2019 /PRNewswire/ — Novo Nordisk today
Read moreCompass Pathways Receives FDA Approval for Psilocybin Therapy Clinical Trial for Treatment-resistant Depression
LONDON, August 22, 2018 /PRNewswire/ — Compass Pathways apothekegenerika.de, a
Read more